All posts

Green Thumb is a bargain of a pot stock, says Beacon Securities

If you’re looking for a cannabis stock with plenty of upside potential, look no further than Chicago-based Green Thumb Industries (Green Thumb Industries Stock Quote, Chart, News CSE:GTII), says Beacon Securities analyst Russell Stanley.

The analyst delivered an update on Green Thumb to clients on Tuesday, saying GTI’s position continues to strengthen in home state Illinois.

US cannabis MSO Green Thumb, which has 13 manufacturing facilities, licenses for 96 retail locations and operations across 12 US markets, announced on Tuesday the opening on May 28 of Rise Niles, the company’s eighth store in Illinois, and 45th in the country.

Rise Niles makes three adult-use openings in the state of Illinois this year and now six new stores in 2020 across the US.

Speaking to the opening as well as the company’s response to the COVID-19 crisis, CEO and founder Ben Kovler said, “We have continued to move forward through the ongoing COVID-19 crisis to provide jobs and much needed access to well-being through the power of cannabis during these difficult times, as demonstrated by the opening of Rise Niles, our fourth opening since the crisis began. Our retail team has pivoted quickly and efficiently as regulations evolve and we are profoundly grateful for their dedication and service to our customers.”

The company noted the continuing strength of the Illinois adult-use market, which commenced in January, quoting April’s total adult-use sales of over $37 million, which were better than the previous two months and leading to a total of $148 million since January 1. (All figures in US dollars except where noted otherwise.)

In his coverage, Stanley pointed out that Illinois’ April sales were up four per cent month-over-month growth in both its adult-use and medical sales.

“The company is licensed to add two more adult-use only retail locations in this state, and we remain optimistic that the medical-only location in Naperville may be converted to a combined medical/adult-use store at some point in 2020. GTII also operates two of just 21 licensed cultivation/manufacturing operations in Illinois (Rock Island, Oglesby), both of which are currently being expanded. These initiatives position GTII very well for continued wholesale and retail growth in the company’s home market,” Stanley wrote.

By his estimates, Stanley called GTI the free cash flow leader based on first quarter numbers from US MSOs so far at $14 million for its Q1, released earlier this month. The analyst said he expects Green Thumb to be cash flow from operations positive for every quarter this year, leading to 2020 CFO of $73 million. For the year, Stanley is calling for revenue of $453 million and attributable EBITDA of $132 million, while for fiscal 2021, he is estimating $760 million in revenue and $272 million in attributable EBITDA.

Stanley calculates GTI to be currently trading at a 34 per cent discount from its US operator peer average and at a 41 per cent discount to its broader peer group.

Stanley concluded his update by saying, “The stock has very strong momentum that should carry it through the test of an important resistance zone.”

Tagged with: gtii
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Buy this “down in the dumps” Canadian stock, fund manager says

Barry Schwartz, president and chief investment officer at Baskin Wealth Management, told BNN Bloomberg’s Market Watch on Sept. 2 that… [Read More]

16 hours ago

AI saved Google’s search monopoly, this analyst says

Roth Capital Markets analyst Rohit Kulkarni maintained a “Buy” rating and US$210.00 target price on Alphabet (Alphabet Stock Quote, Chart,… [Read More]

17 hours ago

Is Perimeter Medical Imaging a buy?

Paradigm Capital analyst Scott McAuley maintained a “Speculative Buy” rating but lowered his target price for Perimeter Medical Imaging AI… [Read More]

21 hours ago

Should you sell your Amazon stock?

Roth Capital Markets analyst Rohit Kulkarni maintained a “Buy” rating and 12-month price target of $250.00 on Amazon.com (Amazon.com Stock… [Read More]

21 hours ago

Analyst names this small Canadian stock a “Top Pick”

Paradigm Capital analyst Alexandra Ricci maintained a “Buy” rating on Tornado Infrastructure Equipment (Tornado Infrastructure Equipment Stock Quote, Chart, News,… [Read More]

21 hours ago

Questor Technology upgraded by ATB Capital

ATB Capital Markets analyst Tim Monachello raised his rating on Questor Technology (Questor Technology Stock Quote, Chart, News, Analysts, Financials… [Read More]

2 days ago